RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Report

RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases), By End-User, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-049-3
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

RNA-targeting Small Molecule Drug Discovery Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Infectious Diseases
- Metabolic Diseases
- Neurological Diseases
- Others
RNA-targeting Small Molecule Drug Discovery End-User Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
- Others
RNA-targeting Small Molecule Drug Discovery Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America RNA-targeting Small Molecule Drug Discovery Market, by Indication
    - Cancer
    - Infectious Diseases
    - Metabolic Diseases
    - Neurological Diseases
    - Others
  - North America RNA-targeting Small Molecule Drug Discovery Market, by End-User
    - Pharmaceutical and Biopharmaceutical Companies
    - Academic and Research Institutes
    - Others
  - U.S.
    - U.S. RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - U.S. RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Canada
    - Canada RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Canada RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
- Europe
  - Europe RNA-targeting Small Molecule Drug Discovery Market, by Indication
    - Cancer
    - Infectious Diseases
    - Metabolic Diseases
    - Neurological Diseases
    - Others
  - Europe RNA-targeting Small Molecule Drug Discovery Market, by End-User
    - Pharmaceutical and Biopharmaceutical Companies
    - Academic and Research Institutes
    - Others
  - U.K.
    - U.K. RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - U.K. RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Germany
    - Germany RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Germany RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - France
    - France RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - France RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Italy
    - Italy RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Italy RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Spain
    - Spain RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Spain RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Denmark
    - Denmark RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Denmark RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Sweden
    - Sweden RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Sweden RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Norway
    - Norway RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Norway RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
- Asia Pacific
  - Asia Pacific RNA-targeting Small Molecule Drug Discovery Market, by Indication
    - Cancer
    - Infectious Diseases
    - Metabolic Diseases
    - Neurological Diseases
    - Others
  - Asia Pacific RNA-targeting Small Molecule Drug Discovery Market, by End-User
    - Pharmaceutical and Biopharmaceutical Companies
    - Academic and Research Institutes
    - Others
  - Japan
    - Japan RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Japan RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - China
    - China RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - China RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - India
    - India RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - India RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Australia
    - Australia RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Australia RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Thailand
    - Thailand RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Thailand RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - South Korea
    - South Korea RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - South Korea RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
- Latin America
  - Latin America RNA-targeting Small Molecule Drug Discovery Market, by Indication
    - Cancer
    - Infectious Diseases
    - Metabolic Diseases
    - Neurological Diseases
    - Others
  - Latin America RNA-targeting Small Molecule Drug Discovery Market, by End-User
    - Pharmaceutical and Biopharmaceutical Companies
    - Academic and Research Institutes
    - Others
  - Brazil
    - Brazil RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Brazil RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Mexico
    - Mexico RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Mexico RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Argentina
    - Argentina RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Argentina RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
- Middle East & Africa
  - Middle East & Africa RNA-targeting Small Molecule Drug Discovery Market, by Indication
    - Cancer
    - Infectious Diseases
    - Metabolic Diseases
    - Neurological Diseases
    - Others
  - Middle East & Africa RNA-targeting Small Molecule Drug Discovery Market, by End-User
    - Pharmaceutical and Biopharmaceutical Companies
    - Academic and Research Institutes
    - Others
  - South Africa
    - South Africa RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - South Africa RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Saudi Arabia
    - Saudi Arabia RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Saudi Arabia RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - UAE
    - UAE RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - UAE RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others
  - Kuwait
    - Kuwait RNA-targeting Small Molecule Drug Discovery Market, by Indication
      - Cancer
      - Infectious Diseases
      - Metabolic Diseases
      - Neurological Diseases
      - Others
    - Kuwait RNA-targeting Small Molecule Drug Discovery Market, by End-User
      - Pharmaceutical and Biopharmaceutical Companies
      - Academic and Research Institutes
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.